Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists

• 收藏
• 分享

专利权人:

Cumberland Pharmaceuticals Inc.

发明人:

Leo PAVLIV,Martin OGLETREE

申请号：

US16781445

公开号：

US20200171007A1

申请日:

2020.02.04

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention is directed to methods of treating hepatorenal syndrome by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist to a patient in need thereof. The present invention is also directed to methods of treating hepatic encephalopathy and cerebral edema by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist to a patient in need thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/